Click here to get full coverage on ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP)  ChartMill

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Click here to get full coverage on Aspire Biopharma (NASDAQ: ASBP) details sublingual pipeline and financings - Stock Titan

Aspire Biopharma (NASDAQ: ASBP) details sublingual pipeline and financings  Stock Titan

Aspire Biopharma (NASDAQ: ASBP) details sublingual pipeline and financings - Stock Titan

Click here to get full coverage on ASBP honors AIT company for repeatedly serving battle buddies through blood donations - army.mil

ASBP honors AIT company for repeatedly serving battle buddies through blood donations  army.mil

ASBP honors AIT company for repeatedly serving battle buddies through blood donations - army.mil

Click here to get full coverage on ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin – Retail Expects Licensing Negotiations Soon - Stocktwits

ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin – Retail Expects Licensing Negotiations Soon  Stocktwits

ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin – Retail Expects Licensing Negotiations Soon - Stocktwits

Click here to get full coverage on Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Wausau Daily Herald

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack  Wausau Daily Herald

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Wausau Daily Herald

Click here to get full coverage on Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Visalia Times-Delta

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements  Visalia Times-Delta

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Visalia Times-Delta

Click here to get full coverage on This caffeine powder skips the drink and is heading to stores nationwide - Stock Titan

This caffeine powder skips the drink and is heading to stores nationwide  Stock Titan

This caffeine powder skips the drink and is heading to stores nationwide - Stock Titan

Click here to get full coverage on FLW to serve as the heart of ASBP winter blood drive - army.mil

FLW to serve as the heart of ASBP winter blood drive  army.mil

FLW to serve as the heart of ASBP winter blood drive - army.mil

Click here to get full coverage on Aspire Biopharma (Nasdaq: ASBP) gains extension, moves to Nasdaq Capital Market - Stock Titan

Aspire Biopharma (Nasdaq: ASBP) gains extension, moves to Nasdaq Capital Market  Stock Titan

Aspire Biopharma (Nasdaq: ASBP) gains extension, moves to Nasdaq Capital Market - Stock Titan

Click here to get full coverage on New meclizine powder aims to cut Dramamine wait from an hour to minutes - Stock Titan

New meclizine powder aims to cut Dramamine wait from an hour to minutes  Stock Titan

New meclizine powder aims to cut Dramamine wait from an hour to minutes - Stock Titan

Click here to get full coverage on Sprinkle-under-tongue caffeine sticks arrive at major 2026 fitness show - Stock Titan

Sprinkle-under-tongue caffeine sticks arrive at major 2026 fitness show  Stock Titan

Sprinkle-under-tongue caffeine sticks arrive at major 2026 fitness show - Stock Titan

Click here to get full coverage on Sublingual aspirin powder targets emergency heart attack treatment - Stock Titan

Sublingual aspirin powder targets emergency heart attack treatment  Stock Titan

Sublingual aspirin powder targets emergency heart attack treatment - Stock Titan

Click here to get full coverage on Caffeine stick packs hit Palm Springs resorts ahead of Coachella - Stock Titan

Caffeine stick packs hit Palm Springs resorts ahead of Coachella  Stock Titan

Caffeine stick packs hit Palm Springs resorts ahead of Coachella - Stock Titan

Click here to get full coverage on FDA backs trial of faster-acting aspirin powder for heart attacks - Stock Titan

FDA backs trial of faster-acting aspirin powder for heart attacks  Stock Titan

FDA backs trial of faster-acting aspirin powder for heart attacks - Stock Titan

Click here to get full coverage on Aspire Biopharma (ASBP) seeks reverse split, $100M equity line and share increase - Stock Titan

Aspire Biopharma (ASBP) seeks reverse split, $100M equity line and share increase  Stock Titan

Aspire Biopharma (ASBP) seeks reverse split, $100M equity line and share increase - Stock Titan

Click here to get full coverage on New under-the-tongue Xanax powder aims to calm panic attacks in minutes - Stock Titan

New under-the-tongue Xanax powder aims to calm panic attacks in minutes  Stock Titan

New under-the-tongue Xanax powder aims to calm panic attacks in minutes - Stock Titan

Click here to get full coverage on BUZZ BOMB caffeine gets sleek new look and direct-to-consumer website - Stock Titan

BUZZ BOMB caffeine gets sleek new look and direct-to-consumer website  Stock Titan

BUZZ BOMB caffeine gets sleek new look and direct-to-consumer website - Stock Titan

Click here to get full coverage on Veteran markets executive joins Aspire to push rapid-onset drug platform - Stock Titan

Veteran markets executive joins Aspire to push rapid-onset drug platform  Stock Titan

Veteran markets executive joins Aspire to push rapid-onset drug platform - Stock Titan

Click here to get full coverage on Tiny drug developer shrinks share count 40-to-1 to keep Nasdaq listing - Stock Titan

Tiny drug developer shrinks share count 40-to-1 to keep Nasdaq listing  Stock Titan

Tiny drug developer shrinks share count 40-to-1 to keep Nasdaq listing - Stock Titan

Click here to get full coverage on Ashley Paulson’s 100-mile world record drives 400K Buzz Bomb views - Stock Titan

Ashley Paulson’s 100-mile world record drives 400K Buzz Bomb views  Stock Titan

Ashley Paulson’s 100-mile world record drives 400K Buzz Bomb views - Stock Titan

Click here to get full coverage on Drug developer Aspire Biopharma secures Nasdaq spot with $2.5M equity - Stock Titan

Drug developer Aspire Biopharma secures Nasdaq spot with $2.5M equity  Stock Titan

Drug developer Aspire Biopharma secures Nasdaq spot with $2.5M equity - Stock Titan

Click here to get full coverage on He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan

He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him  Stock Titan

He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan

Click here to get full coverage on 15M Plavix prescriptions: Aspire under-tongue powder targets gastric irritation - Stock Titan

15M Plavix prescriptions: Aspire under-tongue powder targets gastric irritation  Stock Titan

15M Plavix prescriptions: Aspire under-tongue powder targets gastric irritation - Stock Titan

Click here to get full coverage on ASBP SEC Filings - Aspire Biopharma Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan

ASBP SEC Filings - Aspire Biopharma Holdings Inc 10-K, 10-Q, 8-K Forms  Stock Titan

ASBP SEC Filings - Aspire Biopharma Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Breakthrough 2-Minute Heart Attack Treatment: Aspire's Sublingual Aspirin Beats Standard Tablets in Clinical Tests - Stock Titan

Breakthrough 2-Minute Heart Attack Treatment: Aspire's Sublingual Aspirin Beats Standard Tablets in Clinical Tests  Stock Titan

Breakthrough 2-Minute Heart Attack Treatment: Aspire's Sublingual Aspirin Beats Standard Tablets in Clinical Tests - Stock Titan

Click here to get full coverage on Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - The News Leader | Staunton, VA

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution  The News Leader | Staunton, VA

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - The News Leader | Staunton, VA

Click here to get full coverage on Why Is Aspire Biopharma Stock (ASBP) Up Today? - TipRanks

Why Is Aspire Biopharma Stock (ASBP) Up Today?  TipRanks

Why Is Aspire Biopharma Stock (ASBP) Up Today? - TipRanks

Click here to get full coverage on News - Armed Services Blood Program celebrates donors’ life-giving efforts - DVIDS

News - Armed Services Blood Program celebrates donors’ life-giving efforts  DVIDS

News - Armed Services Blood Program celebrates donors’ life-giving efforts - DVIDS

Click here to get full coverage on Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall - Investing.com

Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall  Investing.com

Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall - Investing.com

Click here to get full coverage on Aspire Biopharma Holdings Signs Debt-for-Equity Exchange Agreements With Certain Debt Holders - TradingView

Aspire Biopharma Holdings Signs Debt-for-Equity Exchange Agreements With Certain Debt Holders  TradingView

Aspire Biopharma Holdings Signs Debt-for-Equity Exchange Agreements With Certain Debt Holders - TradingView

Click here to get full coverage on 1/15/2026 Market Update - Winners: ASBP, CJMB, AHMA - Losers: MTVA, IVP, ECDA - S&P 500: 0.3% - Trefis

1/15/2026 Market Update - Winners: ASBP, CJMB, AHMA - Losers: MTVA, IVP, ECDA - S&P 500: 0.3%  Trefis

1/15/2026 Market Update - Winners: ASBP, CJMB, AHMA - Losers: MTVA, IVP, ECDA - S&P 500: 0.3% - Trefis

Click here to get full coverage on Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

Aspire Biopharma Holdings, Inc. SEC 10-Q Report  TradingView

Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on Aspire Biopharma Holdings Signs Multiple Material Agreements - TradingView

Aspire Biopharma Holdings Signs Multiple Material Agreements  TradingView

Aspire Biopharma Holdings Signs Multiple Material Agreements - TradingView

Click here to get full coverage on Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching - TechStock²

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching  TechStock²

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching - TechStock²

Click here to get full coverage on Revolutionary Pre-Workout Supplement Acts in Seconds, Not Minutes: Early Users Praise Instant Energy Boost - Stock Titan

Revolutionary Pre-Workout Supplement Acts in Seconds, Not Minutes: Early Users Praise Instant Energy Boost  Stock Titan

Revolutionary Pre-Workout Supplement Acts in Seconds, Not Minutes: Early Users Praise Instant Energy Boost - Stock Titan

Click here to get full coverage on Aspire Biopharma Provides Q3 2025 Business Update - Yahoo Finance

Aspire Biopharma Provides Q3 2025 Business Update  Yahoo Finance

Aspire Biopharma Provides Q3 2025 Business Update - Yahoo Finance

Click here to get full coverage on Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA) - Yahoo Finance

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)  Yahoo Finance

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA) - Yahoo Finance

Click here to get full coverage on Revolutionary Pre-Workout BUZZ BOMB Launches With Instant-Action Technology | ASBP Stock News - Stock Titan

Revolutionary Pre-Workout BUZZ BOMB Launches With Instant-Action Technology | ASBP Stock News  Stock Titan

Revolutionary Pre-Workout BUZZ BOMB Launches With Instant-Action Technology | ASBP Stock News - Stock Titan

Click here to get full coverage on Aspire Biopharma Provides Q3 2025 Business Update - The Herald-Mail

Aspire Biopharma Provides Q3 2025 Business Update  The Herald-Mail

Aspire Biopharma Provides Q3 2025 Business Update - The Herald-Mail

Click here to get full coverage on Aspire Biopharma Holdings sets share limit for stock incentive plan and approves equity award agreements - Investing.com

Aspire Biopharma Holdings sets share limit for stock incentive plan and approves equity award agreements  Investing.com

Aspire Biopharma Holdings sets share limit for stock incentive plan and approves equity award agreements - Investing.com

Click here to get full coverage on Aspire Biopharma (ASBP) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Aspire Biopharma (ASBP) FDA Approvals, PDUFA Dates & Drug Alerts 2026  MarketBeat

Aspire Biopharma (ASBP) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Click here to get full coverage on Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M - TradingView

Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M  TradingView

Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M - TradingView

Click here to get full coverage on Aspire Biopharma announces 1-for-40 reverse stock split - Investing.com

Aspire Biopharma announces 1-for-40 reverse stock split  Investing.com

Aspire Biopharma announces 1-for-40 reverse stock split - Investing.com

Click here to get full coverage on Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Yahoo Finance

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity  Yahoo Finance

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Yahoo Finance

Click here to get full coverage on Aspire Biopharma Holdings files for Series A convertible preferred stock on Nasdaq - Investing.com

Aspire Biopharma Holdings files for Series A convertible preferred stock on Nasdaq  Investing.com

Aspire Biopharma Holdings files for Series A convertible preferred stock on Nasdaq - Investing.com

Click here to get full coverage on Aspire Biopharma partners with Microsize for sublingual aspirin development - Investing.com

Aspire Biopharma partners with Microsize for sublingual aspirin development  Investing.com

Aspire Biopharma partners with Microsize for sublingual aspirin development - Investing.com

Click here to get full coverage on FDA feedback clears path for Aspire Biopharma’s heart attack drug - Investing.com

FDA feedback clears path for Aspire Biopharma’s heart attack drug  Investing.com

FDA feedback clears path for Aspire Biopharma’s heart attack drug - Investing.com

Click here to get full coverage on Aionex Doubles Down on Thailand: Strategic Investment Powers ASBP, an Open Platform to Scale up the Two-wheeler EV Transformation - Focus Taiwan

Aionex Doubles Down on Thailand: Strategic Investment Powers ASBP, an Open Platform to Scale up the Two-wheeler EV Transformation  Focus Taiwan

Aionex Doubles Down on Thailand: Strategic Investment Powers ASBP, an Open Platform to Scale up the Two-wheeler EV Transformation - Focus Taiwan

Click here to get full coverage on Aspire Biopharma (ASBP) Stock Price, News & Analysis - MarketBeat

Aspire Biopharma (ASBP) Stock Price, News & Analysis  MarketBeat

Aspire Biopharma (ASBP) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback - Yahoo Finance

Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback  Yahoo Finance

Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback - Yahoo Finance

Click here to get full coverage on Aspire Biopharma gets Nasdaq extension to meet listing requirements - Investing.com

Aspire Biopharma gets Nasdaq extension to meet listing requirements  Investing.com

Aspire Biopharma gets Nasdaq extension to meet listing requirements - Investing.com

Click here to get full coverage on Aspire Biopharma Provides Q3 2025 Business Update - Palm Beach Daily News

Aspire Biopharma Provides Q3 2025 Business Update  Palm Beach Daily News

Aspire Biopharma Provides Q3 2025 Business Update - Palm Beach Daily News

Click here to get full coverage on Aspire Biopharma files patent for first sublingual alprazolam powder - Investing.com

Aspire Biopharma files patent for first sublingual alprazolam powder  Investing.com

Aspire Biopharma files patent for first sublingual alprazolam powder - Investing.com

Click here to get full coverage on Aspire Biopharma enters $9.7 million note purchase agreement with investors By Investing.com - Investing.com

Aspire Biopharma enters $9.7 million note purchase agreement with investors By Investing.com  Investing.com

Aspire Biopharma enters $9.7 million note purchase agreement with investors By Investing.com - Investing.com

Click here to get full coverage on ASBP stock touches 52-week low at $0.22 amid sharp annual decline - Investing.com

ASBP stock touches 52-week low at $0.22 amid sharp annual decline  Investing.com

ASBP stock touches 52-week low at $0.22 amid sharp annual decline - Investing.com

Click here to get full coverage on Video - Donate Blood Today at the ASBP Blood Drive - DVIDS

Video - Donate Blood Today at the ASBP Blood Drive  DVIDS

Video - Donate Blood Today at the ASBP Blood Drive - DVIDS

Click here to get full coverage on Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication - Yahoo Finance

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication  Yahoo Finance

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication - Yahoo Finance

Click here to get full coverage on Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements - Yahoo Finance

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements  Yahoo Finance

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements - Yahoo Finance

Click here to get full coverage on Aspire Biopharma regains Nasdaq compliance requirements - Investing.com

Aspire Biopharma regains Nasdaq compliance requirements  Investing.com

Aspire Biopharma regains Nasdaq compliance requirements - Investing.com

Click here to get full coverage on Aspire Biopharma reports positive reception at CPHI Frankfurt event - Investing.com

Aspire Biopharma reports positive reception at CPHI Frankfurt event  Investing.com

Aspire Biopharma reports positive reception at CPHI Frankfurt event - Investing.com

Click here to get full coverage on Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors - Yahoo Finance

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors  Yahoo Finance

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors - Yahoo Finance

Click here to get full coverage on Aspire Biopharma regains Nasdaq minimum bid price compliance - Investing.com

Aspire Biopharma regains Nasdaq minimum bid price compliance  Investing.com

Aspire Biopharma regains Nasdaq minimum bid price compliance - Investing.com

Click here to get full coverage on ASBP Stock Price, News & Analysis | Aspire Biopharma Holdings - Stock Titan

ASBP Stock Price, News & Analysis | Aspire Biopharma Holdings  Stock Titan

ASBP Stock Price, News & Analysis | Aspire Biopharma Holdings - Stock Titan

Click here to get full coverage on Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product - Yahoo Finance

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product  Yahoo Finance

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product - Yahoo Finance

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget

Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop?  Bitget

Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget

Click here to get full coverage on Aspire Biopharma Approves Key Proposals at Special Meeting - TipRanks

Aspire Biopharma Approves Key Proposals at Special Meeting  TipRanks

ASBP

Price Chart

Key Statistics

Technicals

About ASBP

Latest News

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Aspire Biopharma (NASDAQ: ASBP) details sublingual pipeline and financings - Stock Titan

ASBP honors AIT company for repeatedly serving battle buddies through blood donations - army.mil

Advanced Charts

Top Gainers

Top Losers